Table 4.
Item2 | Treatment1 | SEM | P-value | |||||
---|---|---|---|---|---|---|---|---|
NC | PC | AGP | PBT | NC vs. PC | PC vs. AGP | PC vs. PBT | ||
MDA, nmol/mg of protein | 0.74 | 0.73 | 1.11 | 1.00 | 0.16 | 0.968 | 0.101 | 0.244 |
Protein carbonyl, nmol/mg protein | 0.76 | 1.12 | 1.20 | 1.11 | 0.10 | 0.016 | 0.620 | 0.906 |
IgG, µg/mg of protein | 2.47 | 3.08 | 2.41 | 3.61 | 0.41 | 0.302 | 0.258 | 0.333 |
IgA, µg/mg of protein | 2.88 | 4.10 | 2.69 | 3.19 | 0.48 | 0.080 | 0.052 | 0.184 |
TNF-α, pg/mg of protein | 0.88 | 0.99 | 0.72 | 0.67 | 0.21 | 0.714 | 0.372 | 0.287 |
IL-6, pg/mg of protein | 0.75 | 0.70 | 0.65 | 0.62 | 0.13 | 0.818 | 0.783 | 0.653 |
IL-8, pg/mg of protein | 0.42 | 0.77 | 0.48 | 0.42 | 0.14 | 0.073 | 0.142 | 0.078 |
Treatments: NC, no-challenge/no-supplement; PC, E. coli challenge/no-supplement; AGP, E. coli challenge/bacitracin (30 g/t feed); and PBT, E. coli challenge/LBF (2 kg/t feed; LBiotix, Adare Biome, Houdan, France).
IgG, immunoglobulin G; IgA, immunoglobulin A; IL-6, interleukin-6; IL-8, interleukin-8; MDA, malondialdehyde; TNF-α, tumor necrosis factor-alpha